VIDA VENTURES ADVISORS
VIDA VENTURES ADVISORS is a Pre-seed, Seed, Series A, Series B and Series C+ fund in the US writing $100K–$10M checks into Healthcare, pharma-tech, oncology, immunology, car-t, radiopharmaceuticals, precision-medicine, autoimmune-diseases, genetic-medicines and neurodegeneration.
- Stages
- Pre-seed, Seed, Series A, Series B, Series C+
- Sectors
- Healthcare, pharma-tech, oncology, immunology, car-t, radiopharmaceuticals, precision-medicine, autoimmune-diseases, genetic-medicines, neurodegeneration
- Check size
- $100K–$10M
- Invests in
- US-wide
- Actively investing
- Yes
- Founded
- 2017
- Assets under management
- $1.8B
- Website
- vidaventures.com
Thesis
VIDA Ventures targets early-stage investments in biomedical companies across the United States, investing from Friends & Family to Growth Equity, with a focus on therapeutics. VIDA Ventures seeks to partner with founders committed to advancing innovative solutions in areas such as Biotech, Healthcare, Pharma-tech, Oncology, Immunology, CAR-T, Radiopharmaceuticals, Precision medicine, Autoimmune diseases, Genetic medicines, and Neurodegeneration. VIDA Ventures manages approximately $1.8 billion in assets, with its third fund, Vida III, having a fund size of $600 million. VIDA Ventures aims to identify and invest in transformative biomedical innovations with the potential to impact patients meaningfully.
Common questions
Does VIDA VENTURES ADVISORS invest at the Pre-seed stage?
Yes. VIDA VENTURES ADVISORS lists Pre-seed, Seed, Series A, Series B and Series C+ among the stages it invests in.
What check size does VIDA VENTURES ADVISORS write?
VIDA VENTURES ADVISORS writes $100K–$10M checks.
Where does VIDA VENTURES ADVISORS invest?
VIDA VENTURES ADVISORS invests in the US.